Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New Player Enters the Swedish Investment Scene

Aldeon to focus on early stage founders within games & techStockholm (Jan 26, 2020) - Spearheaded by industry and entreprenural veterans Daniel Laurén, Susana Meza Graham, and Andras Vajlok, Aldeon is a newly formed independent investment company focused on working with games and tech start-ups in their early stages. The new initiative currently has 20 holdings, acquired by its three founders over a number of years.  Aldeon's focus will primarily be on local entrepreneurs in the Nordics as the founders believe there is strength in proximity combined with the incredible hotbed of talent

Strong development for Hudya

- Strong sales development, lower costs for customer acquisition and intent agreement with Optin BankThe fintech company Hudya - which carries out a new share issue and listing process at the Nasdaq First North Growth Market - has had a strong development, both in terms of sales and ever-lower costs for customer acquisition. In addition, Hudya has signed an important letter of intent with Optin Bank regarding payment solutions. - We are very pleased with how sales are developing and that we have low costs for our customer acquisition. An important part of our strong sales development is

Oncopeptides will host a webcast on Monday, January 27[th] at 11.00 (CET)

STOCKHOLM — January 24, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27[th] 2020 where CEO Jakob Lindberg will present and explain melflufen’s mechanism of action.Conference call for investors, analysts and the media, Monday, January 27[th] 2020, at 11 (CET). Phone numbers for participants from: Sweden: +46 8 505 58 352Europe: +44 3333 009 262USA: +1 833 526 8347 The conference call will also be streamed on the corporate website www.oncopeptides.com and via the link below. https://tv.

Prestigious sustainability award to Xavi and Genexis

Genexis, the product company of Inteno Group, and its ODM partner Xavi have recieved the prestigious JAC sustainability and CSR certification. The Joint Audit Cooperation (JAC, jac-initiative.com) is a collective of 17 telecommunication companies, including Telia, Telenor, KPN, Elisa, AT&T, Deutsche Telekom and Vodafone. The purpose is to promote safe and fair working conditions as well as responsible, social and environmental management by verifying, assessing and promoting sustainability standards and transfer of best practice across the supply chain. “We are proud to receive

Correction Statement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION. THIS PUBLICATION IS NEITHER AN OFFER TO BUY OR SELL NOR AN INVITATION TO TENDER OR OFFER TO BUY OR SELL SHARES.   Read the whole press release here .   About RecipharmRecipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 7,000 employees. Recipharm offers manufacturing

Adapteo Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Adapteo Plc Regulatory press release 24 January 2020 at 17:00 p.m. CET Adapteo Plc (the “Company”) has on 23 January 2020 received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Nordea Funds Ltd. According to the notification, the holding of Nordea Funds Ltd in the Company’s shares and votes has fallen below 5 per cent on 22 January 2020. Nordea Funds Ltd holds a total of 2,171,702 shares and 2,224,910 voting rights corresponding to an ownership of 4.86 percent in Adapteo’s shares and 4.98 percent in votes. Adapteo has a total of 44,682,697

NOTICE OF EXTRAORDINARY GENERAL MEETING AT SCANDINAVIAN ENVIRO SYSTEMS AB (publ)

Shareholders of Scandinavian Enviro Systems AB (publ) (the Company), co. reg. no. 556605-6726, are hereby invited to an Extraordinary General Meeting on Thursday, February 27, 2020 at 16:00 at Hotel Kusten, Kustgatan 10, SE 414 55 Gothenburg, Sweden. Registration for the meeting will commence at 15:30.N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. NOTIFICATIONShareholders who wish to attend the meeting must: i. be entered in the share register

#20-26 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#20-25 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Comment to the founders’ sale of shares

The two founders of ODI Pharma AB (“ODI” or “Company”), Derek Simmross and Volker Wiederrich, yesterday sold a part of their respective holdings in the Company. The total sale amounts to 251,166 shares. The founders’ holdings prior to the IPO remains, and the founders have no intention to sell more than what has already been sold.Derek Simmross, CEO, and Volker Wiederrich, Chairman of the Board, comment “We have understood that the share sale we made yesterday has caused some concern. We want to clarify the reasons behind the sale, which are personal financial reasons as we have not, and

Invitation - DNB's fourth quarter results for 2019 will be presented on Thursday 6 February

DNB will publish its results for the fourth quarter of 2019 on Thursday 6 February 2020 at 7.30 a.m. CET. Thursday 6 February at 9:30 am CET: press conference in English accessible via live web TVPlace: DNB's head office in Bjørvika, Dronning Eufemias gate 30, Oslo. A live broadcast will be available on the Investor Relations pages at ir.dnb.no.Please register your attendance in Oslo by email to ca@dnb.no. Thursday 6 February at 1:30 pm CET: conference call for analysts and investorsTo attend the conference call: (+47) 21 56 33 18, or International line: (+44) (0) 20 30 03 26 66.

Inhalation Sciences signs CRO contract worth 750 KSEK with global corporation based in Europe

(Stockholm 24 January, 2020) Inhalation Sciences (ISAB) has signed a CRO (Contract research) order worth 750 KSEK with a returning customer who has carried out extensive previous CRO with ISAB, and purchased ISAB lab systems.The total value of the order is 1.1 MSEK. 750 KSEK is for services provided by ISAB, and the remaining 350 KSEK to other research companies collaborating on the project. This CRO will employ ISAB’s novel in vitro simulation tool DissolvIt, and its IPL (Isolated Perfuse Lung) module. ISAB CEO Manoush Masarrat “When clients of this calibre return time and again, it

Publication of a Prospectus

RNS ANNOUNCEMENT    Royal Bank of CanadaJanuary 24, 2020  Publication of Prospectus Not for release, publication or distribution, directly or indirectly, in or into the United States. Royal Bank of Canada has agreed to issue GBP350,000,000 1.125 per cent. Senior Notes due December 15, 2025, Series 53132 (the "Notes") pursuant to its Programme for the Issuance of Securities (the "Programme"). The following document constitutes the final terms dated January 24, 2020 (the "Final Terms") relating to the admission to trading of the Notes for purpose of Article 5.4 of

PEN has received an order for a new design concept and furniture to restaurant Smak in Falun.

PEN Concept Group AB (PENCON, Spotlight Stock Market) has, through its subsidiary PEN Products AB, received orders for restaurant furniture for restaurant Smak in Falun, which will change to a new interior design concept in quarter one. PEN has been responsible for both design proposals and product selection for the new concept. The customer already operates several restaurants in Falun and this restaurant will be a good complement to the rest. Delivery will take place during quarter one 2020. The total order value amounts to approximately SEK 0.4 million. Magnus Hjorth, CEO of PEN

Lipidor announces positive topline results of AKP01 Phase III clinical study using calcipotriol spray against psoriasis

Lipidor AB (Nasdaq First North: LIPI) today reports positive topline results of its AKP01 Phase III clinical study, using calcipotriol spray against mild to moderate plaque psoriasis. The randomised 277-patient study achieved its primary endpoint demonstrating therapeutic equivalence to comparator measured as reduction of PASI score. Both Lipidor’s AKP01 and the comparator had a statistically significantly better efficacy compared to the placebo.Lipidor has developed a sprayable calcipotriol product, Calcipotriol/AKVANO 50 µg/g cutaneous solution (AKP01), formulated with the company’s

Pro Cycling Team Jumbo Visma met Primoz Roglic naar Ski Classics in Marcialonga

Wielerteam Jumbo-Visma, voegt zich bij Visma Ski Classics in Marcialonga om meer te leren over langeafstandskiën. Visma, de titelsponsor van Visma Ski Classics, brengt skiën en fietsen samen in Marcialonga. Visma is een van de hoofdsponsors van Team Jumbo-Visma en heeft het professionele wielerteam uitgenodigd om mee te doen aan Marcialonga, de zesde etappe van de tour in de Visma Ski Classics. De nummer 1 wielrenner ter wereld, Primoz Roglic, is gewend aan wintersport omdat hij zijn sportcarrière begon met skispringen voordat hij zich volledig op fietsen richtte. In 2019 behaalde

NFL Tipsters take on the 2020 Super Bowl

Super Bowl LIV is just around the corner and ThePlayer.com has the perfect guide for all sports bettors out there.On Sunday February 2nd about 100 million Americans will get in front of the TV to watch who will be crowned champions of the Super Bowl LIV. The grand NFL final is by far the biggest US sports event, and the biggest also when it comes to sports betting."The 2020 Super Bowl is largely a tale of contrasts, of opposites, and of very different philosophies with individually successful results. Both teams feature an abundance of young talent, and the strikingly dissimilar

GADGETS , HEALTH, SMART LIVING & CELEBS TOP THE READLY 2019 REVIEW

The Readly Magazine Review of 2019 reveals what the UK public is interested in.2019 was a year of uncertainty, change and somewhat turbulent times, but what was on the mind of the UK consumer? It wasn’t Boris or Brexit! Each year, Readly the digital magazine service, tracks which magazines are being read across its portfolio of 4500 titles and which issues have been most popular. The data shows that people are most interested in technology, health, celebs and ‘lists’ for efficient, smarter living. The most read issue of the year was T3 ‘101 Gadgets you can’t live without’ which

NRC Group ASA - Appointed to a contract in Sweden - SEK 149 million

The Swedish Transport Administration has appointed NRC Sverige AB, a company wholly owned by NRC Group ASA, to a contract for catenary work on the railway connections Österås-Bispgården, Ramsjö-Ljusdal and Storvik-Gävle in Sweden. The contract is valued at approximately SEK 149 million, and will involve rail services such as electro and groundwork. The work will commence in February 2020, and the project is scheduled for completion in December 2022. Closing date for submission of complaints is 10 days from today, and formal contractual signing can take place after this period at the

Changes in Terveystalo's Executive Team

Veera Siivonen has been appointed SVP, Marketing and Communications of Terveystalo, and Elina Saviharju SVP, Legal of Terveystalo Terveystalo Plc. Stock Exchange Release 24 January 2020 at 15:00 EET Veera Siivonen, b. 1980, M.Sc. Tech, Industrial Engineering has been appointed Senior Vice President, Marketing and Communications of Terveystalo as of 1 May 2020, at the latest. Elina Saviharju, b. 1981, LL.B, LL.M (Harvard) has been appointed Senior Vice President, Legal of Terveystalo. She will join the company as of 24 July 2020, at the latest as Julia Ormio, Chief Legal Officer and

Leading fertilizer company renews payroll and HR services agreement with Zalaris

Zalaris ASA today announced a renewal of the agreement to continue Zalaris’ provision of Multi-Country HR services including Payroll, Time & Attendance, and Travel Expenses for another five-year term, with a large Norwegian industrial company.The renewed agreement encompasses transactional HR services for the company’s operations across Norway, Sweden, Denmark – powered by Zalaris’ proven Multi-Country Cloud solution for payroll, time and travel expenses. The Zalaris solution tightly integrates with the company’s SAP SuccessFactors Employee Central-based global HR solution. Zalaris has

Storebrand Livsforsikring AS: Call of subordinated bond (ISIN NO0010732464)

Storebrand Livsforsikring AS has decided to call the perpetual subordinated bond (ISIN NO0010732464). The bonds will be redeemed at their principal amount on 17 March 2020. The issuer has obtained the consent of the Financial Supervisory Authority of Norway (Finanstilsynet) for such redemption.  Lysaker, 24 January 2020 Contacts:  Group Head of Strategy and Finance, Kjetil R. Krøkjetel +47 934 12 155  Head of Capital Management, Nikola Heitmann tel +47 416 97 236  This information is subject to disclosure requirements pursuant to § 5-12 of the Norwegian Securities Trading

The first patient included in Australia in Isofol's Phase 3 AGENT study

GOTHENBURG, Sweden, January 24 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced that the first patient in Australia has initiated treatment in the global Phase 3 AGENT study.Isofol’s drug candidate arfolitixorin is being evaluated in the first line of treatment of metastatic colorectal cancer (mCRC). The study is currently being conducted in the USA, Canada, Europe and now also in Australia. Isofol plans to start trials in approximately 10 clinics in Australia, in addition to the 80 clinics that are already active. "It is very satisfying that we now

Lifco acquires Dental Grupa D.O.O.

Lifco  has signed an agreement to acquire the majority of the Croatian company Dental Grupa . The company is a leading distributor of dental equipment and consumables in Croatia. In 2019, Dental Grupa reported net sales of approximately 66 MHRK. The company is based in Umag, Croatia and has around 40 employees. The business will be consolidated in Business Area Dental. The acquisition will not have any significant effect on Lifco’s earnings or financial position in current financial year. For more information please contact: Per

There are no items matching the current filter
There are no more items matching the current filter
Back to top